Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical/Finance | Admitted-Fee/PreQual/Technical/Finance |
| 2 | Admitted-Fee/PreQual/Technical/Finance DHIRUBHAI AMBANI LIFE SCIENCES CENTRE R 282 ITC AREA OF MIDC THANE BELAPUR ROAD RABALE NAVI MUMBAI 400701 | NAVI MUMBAI | THANE | MAHARASHTRA | 400701 | Admitted-Fee/PreQual/Technical/Finance |
| 3 | Admitted-Fee/PreQual/Technical/Finance 6TH FLOOR BUILDING NO 8 TOWER C DLF CYBER CITY PHASE II MOTI NAGAR GURGAON WEST DELHI DELHI 122002 | GURUGRAM | HARYANA | 122002 | Admitted-Fee/PreQual/Technical/Finance |
Tender Value
Refer Docs
Closing Date
20 Nov 2023, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MD
O/o AMSCL
Human Albumin Infusion 20 percent
2023_HFWD_33985_1
Human Albumin Infusion 20 percent
Limited
Medicines
Supply
75 days
Guwahati
Please refer Tender documents.
1 document required · 1 mandatory
₹0
Exempted
20 Nov 2023
16 Nov 2023
20 Nov 2023
16 Nov 2023
20 Nov 2023
17 Nov 2023
Electrical Items :
Human Albumin Infusion 20%, 100 ml Bottle/Bag
Takeda Biopharmaceuticals India Private Limited
Reliance Life Sciences Pvt. Ltd
stage.html
html • 0.02 MB
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .